These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7338564)

  • 1. Toxicologic evaluation of bumetanide, potent diuretic agent.
    McClain RM; Dammers KD
    J Clin Pharmacol; 1981; 21(11):543-54. PubMed ID: 7338564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.
    Ward A; Heel RC
    Drugs; 1984 Nov; 28(5):426-64. PubMed ID: 6391889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative acute cochlear toxicity of intravenous bumetanide and furosemide in the purebred beagle.
    Brown RD
    J Clin Pharmacol; 1981; 21(11):620-7. PubMed ID: 7338573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of bumetanide.
    Frey HH
    Postgrad Med J; 1975; 51 Suppl 6():14-18. PubMed ID: 1197201
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative ototoxicity of bumetanide and furosemide when used in combination with kanamycin.
    Brummett RE; Bendrick T; Himes D
    J Clin Pharmacol; 1981; 21(11):628-36. PubMed ID: 7338574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor.
    von Keutz E; Schlüter G
    Am J Cardiol; 1998 Aug; 82(4B):11J-17J. PubMed ID: 9737641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations of the early diuretic response after intravenous administration of bumetanide and furosemide in dogs.
    Olsen UB
    Acta Physiol Scand; 1975 Feb; 93(2):195-201. PubMed ID: 1146571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-clinical toxicological studies with muzolimine.
    Lorke D; Mürmann P
    Curr Med Res Opin; 1976-1977; 4(10):716-24. PubMed ID: 1052163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for diabetogenic action of bumetanide in mice.
    Sandström PE
    Eur J Pharmacol; 1988 May; 150(1-2):35-41. PubMed ID: 3042432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of bumetanide and kanamycin (author's transl)].
    Ohtani I; Ohtsuki K; Omata T; Ouchi J; Saito T
    Nihon Jibiinkoka Gakkai Kaiho; 1978 Jun; 81(6):554-61. PubMed ID: 690746
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of "high ceiling" diuretics on active salt transport in the cortical thick ascending limb of Henle's loop of rabbit kidney. Correlation of chemical structure and inhibitory potency.
    Schlatter E; Greger R; Weidtke C
    Pflugers Arch; 1983 Mar; 396(3):210-7. PubMed ID: 6844125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative acute ototoxicity of intravenous bumetanide and furosemide in the pure-bred beagle.
    Brown RD; Manno JE; Daigneault EA; Manno BR
    Toxicol Appl Pharmacol; 1979 Mar; 48(1 Pt 1):157-69. PubMed ID: 452038
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxicological studies on Etozolin (author's transl)].
    Herrmann M; Wiegleb J; Leuschner F
    Arzneimittelforschung; 1977; 27(9a):1758-67. PubMed ID: 578765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotaxime toxicity studies: a review of preclinical studies and some clinical reports.
    Doerr BI; Glomot R; Kief H; Kramer M; Sakaguchi T
    Rev Infect Dis; 1982; 4 Suppl():S354-9. PubMed ID: 6294784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative evaluation of ototoxic side effects of furosemide, piretanide, bumetanide, azosemide and ozolinone in the cat--a new approach to the problem of ototoxicity.
    Göttl KH; Roesch A; Klinke R
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):275-82. PubMed ID: 4088324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel small-molecule thienoquinolin urea transporter inhibitor acts as a potential diuretic.
    Li F; Lei T; Zhu J; Wang W; Sun Y; Chen J; Dong Z; Zhou H; Yang B
    Kidney Int; 2013 Jun; 83(6):1076-86. PubMed ID: 23486518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bumetanide, frusemide and prostaglandin E2 on the isolated perfused kidney of rat and rabbit.
    Foy JM; Nuhu SZ
    Br J Pharmacol; 1984 May; 82(1):165-73. PubMed ID: 6587927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of 3-n-butylamino-4-phenoxy-5-sulfamylbenzoic acid (Bumetanide), a new potent diuretic.
    Ostergaard EH; Magnussen MP; Nielsen CK; Eilertsen E; Frey HH
    Arzneimittelforschung; 1972 Jan; 22(1):66-72. PubMed ID: 5067001
    [No Abstract]   [Full Text] [Related]  

  • 19. Bumetanide: A preliminary report of its pharmacological properties and therapeutic efficacy in oedema.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1975; 9(1):4-18. PubMed ID: 1126304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical toxicology of bupropion: an overview.
    Tucker WE
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):60-2. PubMed ID: 6406465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.